Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis

Sahil Sekhon, Caleb Jeon, Mio Nakamura, Di Yan, Ladan Afifi, Tina Bhutani, Ethan Levin Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA Abstract: Psoriasis vulgaris is a chronic, immune-mediated systemic...

Full description

Bibliographic Details
Main Authors: Sekhon S, Jeon C, Nakamura M, Yan D, Afifi L, Bhutani T, Levin E
Format: Article
Language:English
Published: Dove Medical Press 2017-11-01
Series:Psoriasis: Targets and Therapy
Subjects:
ixekizumab
biologics
psoriasis
IL-17
anti-IL-17
Online Access:https://www.dovepress.com/clinical-utility-of-ixekizumab-in-the-treatment-of-moderate-to-severe--peer-reviewed-article-PTT

Internet

https://www.dovepress.com/clinical-utility-of-ixekizumab-in-the-treatment-of-moderate-to-severe--peer-reviewed-article-PTT

Similar Items